Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccinations

Vaccinations

Systematic Error: Methodological and Sampling Errors

Systematic Error: Methodological and Sampling Errors

In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring how interprofessional forces shape population-health competencies for clinical pharmacy trainees.

Frontiers in pharmacology·2026

Same author

Evaluation of the Impact of a Pharmacist-Conducted Hypertension Clinic.

Journal of pharmacy & bioallied sciences·2024

Same author

Key Vulnerabilities in the Surgical Environment: Container Mix-Ups and Syringe Swaps Do Not Confuse Idarucizumab with Idarubicin.

Hospital pharmacy·2024

Same author

Avoid Using the Error-Prone Abbreviation "TPA"; Unexpected Painful Breath; Mix-ups among "V" Drugs; <i>Brintellix-Brilinta</i>: Name Change Needed.

Hospital pharmacy·2024

Same author

Methylene Blue is a Monoamine Oxidase Inhibitor; Severe Harm and Death Associated with Low-Dose Methotrexate; Potentially Dangerous Mix-up between Cancer Drugs.

Hospital pharmacy·2024

Same author

Beyond mixed case lettering: reducing the risk of wrong drug errors requires a multimodal response.

BMJ quality & safety·2022

Same journal

Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007-2024) Reported in the ClinicalTrials.gov Database.

Pharmaceutical medicine·2026

Same journal

A Framework for Standardising Toxicity Management Guidelines in Oncology Clinical Trials.

Pharmaceutical medicine·2026

Same journal

Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.

Pharmaceutical medicine·2026

Same journal

An Expert Consensus-Based Review of Considerations for Developing a Quality Management System Framework for Studies Utilising Secondary Data for Real-World Evidence Generation.

Pharmaceutical medicine·2026

Same journal

Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of Levocarnitine.

Pharmaceutical medicine·2026

Same journal

Regulating the Irregular: Phage Therapy and the Case for a Regulatory Sandbox Approach in Australia.

Pharmaceutical medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 2, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Strategies to Reduce Errors Associated with 2-Component Vaccines.

Farzana Samad¹, Samantha J Burton¹, Diana Kwan²

¹Institute for Safe Medication Practices, Horsham, PA, USA.

Pharmaceutical Medicine

|November 5, 2020

Summary

This summary is machine-generated.

Errors with two-component vaccines, like Menveo and Pentacel, are common. Strategies such as improved labeling and staff training can reduce vaccine preparation and administration errors.

More Related Videos

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Related Experiment Videos

Last Updated: Dec 2, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

Area of Science:

Vaccinology
Medication Safety
Pharmaceutical Compounding

Background:

The US Food and Drug Administration (FDA) receives numerous error reports concerning two-component vaccines.
A collaboration between the United States Pharmacopeia (USP) and the Institute for Safe Medication Practices (ISMP) was formed to address these errors.

Purpose of the Study:

To investigate errors associated with two-component vaccines.
To develop strategies for the safe storage, preparation, dispensing, and administration of these vaccines.

Main Methods:

Identified fourteen available two-component vaccines.
Analyzed data from the ISMP National Vaccine Errors Reporting Program (VERP) and the FDA Vaccine Adverse Event Reporting System (VAERS) through December 31, 2019.

Main Results:

Menveo (meningococcal), Pentacel (DTaP, Polio, Hib), and ActHIB (Hib) vaccines had the highest reported reconstitution errors.
Identified specific error patterns in vaccine preparation and administration.

Conclusions:

Manufacturers should enhance vaccine labeling and packaging for easier, safer preparation.
Implementing risk reduction strategies, including staff training and clear storage labeling, is crucial for preventing errors.